|
|
|
|
||
Re: BofA - BMY: Review of Opdualag highlights its potential as a new SoC in solid tumors (Buy PO 78)JPM2022 Slide for Opdualag/Rela+Opdivo Fixed-Dose Combination as Growth Driver #1 |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
9721 | Re: BofA - BMY: Review of Opdualag highlights its potential as a new SoC in solid tumors (Buy PO 78) | Biotech2050 | 0 | 5/26/2022 12:33:33 AM |